189 related articles for article (PubMed ID: 6182911)
21. [Interferon: validity, risks, prospects of clinical use].
Rossi GB; Belardelli F
Epidemiol Prev; 1987 Mar; 9(30):13-5. PubMed ID: 2466676
[No Abstract] [Full Text] [Related]
22. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects.
Billiau A
J Clin Virol; 2007 Aug; 39(4):241-65. PubMed ID: 17580123
[TBL] [Abstract][Full Text] [Related]
23. Treatment of multiple sclerosis with various interferons: the cons.
Johnson KP
Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
[TBL] [Abstract][Full Text] [Related]
24. [Interferon in the treatment of viral, neoplastic and immunologic diseases].
Inglot AD
Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509
[No Abstract] [Full Text] [Related]
25. Interferons: not just alpha.
Krown SE
Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
[No Abstract] [Full Text] [Related]
26. Interferon in viral hepatitis: role in pathogenesis and treatment.
Davis GL; Hoofnagle JH
Hepatology; 1986; 6(5):1038-41. PubMed ID: 2428722
[No Abstract] [Full Text] [Related]
27. [Interferons--biologic principles and clinical uses].
Jacobsen H; Kirchner H
Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
[TBL] [Abstract][Full Text] [Related]
28. Usages of interferon and interferon inducers in man.
Pollard RB
Med Biol; 1980 Apr; 58(2):57-62. PubMed ID: 6159505
[No Abstract] [Full Text] [Related]
29. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
Pollard RB
Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188
[No Abstract] [Full Text] [Related]
30. Drug therapy. Treatment of herpesvirus infections.
Hirsch MS; Schooley RT
N Engl J Med; 1983 Oct; 309(16):963-70. PubMed ID: 6194435
[No Abstract] [Full Text] [Related]
31. Biologicals for cancer treatment: interferons.
Oldham RK
Hosp Pract (Off Ed); 1985 Dec; 20(12):71-4, 78-81, 85-6 passim. PubMed ID: 2415542
[No Abstract] [Full Text] [Related]
32. The clinical implications of human interferon.
Cesario TC
Med Clin North Am; 1983 Sep; 67(5):1147-62. PubMed ID: 6413792
[No Abstract] [Full Text] [Related]
33. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
Fehér J; Lengyel G
Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the study of interferon.
Ho M
Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986
[No Abstract] [Full Text] [Related]
35. [The antiproliferative effects associated with vincristine and human interferons in experimental in vitro systems].
Danielescu G; Maniu H; Jucu V; Cajal N
Virologie; 1989; 40(2):107-13. PubMed ID: 2506692
[TBL] [Abstract][Full Text] [Related]
36. [Interferons: structure, functions and therapeutic applications].
Marcellin P
J Chir (Paris); 1994; 131(8-9):381-90. PubMed ID: 7531204
[No Abstract] [Full Text] [Related]
37. [Interferon as a therapeutic agent].
Borecký L
Cesk Farm; 1982 Jun; 31(5):184-7. PubMed ID: 6180842
[No Abstract] [Full Text] [Related]
38. The interferon system as a basis for antiviral therapy or prophylaxis.
Billiau A
Verh K Acad Geneeskd Belg; 1986; 48(3):187-220. PubMed ID: 2430375
[No Abstract] [Full Text] [Related]
39. Overview of the biology of type I interferons.
Kalliolias GD; Ivashkiv LB
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288
[TBL] [Abstract][Full Text] [Related]
40. [Interferon: its effects and clinical application].
Siegert R
Internist (Berl); 1978 Dec; 19(12):659-63. PubMed ID: 370046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
